Topics:
Genitourinary Cancers • Medical Oncology
What is your preferred subsequent treatment in patients with metastatic bladder cancer with progression on pembrolizumab/enfortumab?
In non-FGFR mutated patients, would you use cisplatin/gemcitabine or sacituzimab govitecan at this point?
Answer from: Medical Oncologist at Community Practice
Given the fundamental change associated with bringing 2 agents, previously approved for salvage therapy after chemotherapy for metastatic urothelial cancer, forward to first line treatment has left practitioners wondering what the correct sequence of therapy should now be in salvage.
This will like...
Sign in or Register to read more